Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 464.6352
- Book/Share 115.1473
- PB 3.3172
- Debt/Equity 0.836
- CurrentRatio 0.8458
- ROIC 0.1255
- MktCap 312729102713.0
- FreeCF/Share 27.7703
- PFCF 12.375
- PE 14.755
- Debt/Assets 0.2566
- DivYield 0.025
- ROE 0.226
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
| Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
| Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
| Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
| Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
| Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
| Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
| Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
| Downgrade | UNH | Argus | Buy | Hold | -- | -- | April 21, 2025 |
| Upgrade | UNH | HSBC Securities | Hold | Buy | -- | $595 | Jan. 10, 2025 |
News
Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.
Read More
UnitedHealth Is Drifting--But The Smart Money Is Buying
Published: August 12, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated is down 56% in a year — yet insiders and big funds are loading up. Q2 earnings disappointed, but new guidance and cost cuts could mark a turning point. My bearish valuation still points to nearly 30% upside for UNH from here.
Read More
Elucid's PlaqueIQ™ Image Analysis Software Now Covered by United Healthcare
Published: August 11, 2025 by: Business Wire
Sentiment: Neutral
BOSTON--(BUSINESS WIRE)-- #histologymatters--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, announced that United Healthcare has updated its cardiac imaging guidelines to fully align with recent recommendations from radiology benefit manager EviCore. United Healthcare's new guidelines now include coronary computed tomography angiography (CTA) plaque quantification (see page 520), specifically enco.
Read More
RiverPark Funds: AI Momentum And Healthcare Headwinds Drive Portfolio Shifts In Q2 2025
Published: August 11, 2025 by: Seeking Alpha
Sentiment: Positive
NVIDIA, Microsoft, and Netflix were top contributors, driven by strong earnings, AI leadership, and robust subscriber/ad growth, reinforcing our long-term conviction in these names. UnitedHealth and Apple underperformed due to margin pressures, regulatory uncertainty, and mixed AI sentiment, but we remain confident in their multi-year value propositions. Our short position in QQQ detracted as tech stocks rallied, but it served as a portfolio hedge without forcing sales of core long holdings.
Read More
UnitedHealth: Much Worse Than Expected
Published: August 11, 2025 by: Seeking Alpha
Sentiment: Negative
UNH's Q2 earnings revealed further weakness with margins at both insurance and Optum plunging to multi-year lows while sales continued to grow at double-digits. Reestablished outlook implies no recovery in profitability during H2 with guided EPS of $16 putting shares at a ~16x fwd P/E, a 3 turn premium to peers. Admitting we have underestimated current challenges, we now see fair value around $275 considering different scenarios for FY26.
Read More
UnitedHealth Group: Membership Growth Indicates Resilience Amid Rising Medical Cost Pressure
Published: August 10, 2025 by: Seeking Alpha
Sentiment: Positive
I reiterate my bullish rating on UNH, supported by strong membership growth and innovative cost-cutting strategies like AI efficiencies and private-label initiatives. UNH is prioritizing affordability and customer retention over aggressive price hikes, leveraging AI and private-label (Nuvaila) to pass cost savings to consumers. Despite recent stock declines and rising medical costs, I project double-digit revenue growth through 2025, with significant upside potential based on valuation metrics.
Read More
UnitedHealth Crashing After Q2 Shock: Should You Panic or Pounce?
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH plunges 12.9% after weak Q2 and slashing 2025 EPS guidance, sparking fears of deeper structural issues ahead.
Read More
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Cigna: Looks More Interesting Here Than UnitedHealth Group
Published: August 06, 2025 by: Seeking Alpha
Sentiment: Positive
Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent earnings were strong, guidance was affirmed, and valuation is attractive, with Wall Street seeing up to 35% upside potential. Risks remain from medical inflation and PBM regulatory scrutiny, but Cigna's business mix provides more pricing power and operational flexibility than UNH.
Read More
UnitedHealth Is Dirt Cheap -- Yet The Comeback Won't Be Quick
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth is deeply undervalued, trading at low P/E and P/FCF multiples despite long-term growth potential and a wide economic moat. Short-term challenges persist: earnings are down, CEO resigned, DoJ investigation ongoing, and higher medical costs are pressuring margins. Management and analysts remain optimistic about a return to double-digit growth, but a quick recovery is unlikely; patience is required.
Read More
UnitedHealth: Time To Double Down (Rating Upgrade)
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth stock plummeted 17.46% after my "Buy" call after missing Q2 EPS expectations by 9%. I see an overreaction creating a strong buying opportunity. Despite Q2 margin and EPS disappointments, management's margin recovery plan and portfolio rationalization should stabilize earnings by 2027. Regulatory risks seem to be subsiding, and with a forward P/S below 0.5x, UNH offers 55-87% upside as sentiment recovers.
Read More
UnitedHealth Q2: Risky To Hold, Riskier To Sell
Published: August 04, 2025 by: Seeking Alpha
Sentiment: Negative
UnitedHealth Group Incorporated's stock is down 53% YTD, and I think it presents a strong long-term buying opportunity at historically low valuations despite near-term headwinds. The company's diversified revenue model, especially Optum's growth in analytics and pharmacy, supports resilient growth, even as FY25 guidance disappointed. Short-term challenges include elevated medical costs, regulatory scrutiny, and Optum Health's revenue decline, but robust cash flow signals underlying strength.
Read More
This banking powerhouse sees 36% rally for UnitedHealth stock
Published: August 04, 2025 by: Finbold
Sentiment: Positive
Shares of UnitedHealth Group (NYSE: UNH) rose 1.2% to $240 on Monday, though the stock remains down 52% year-to-date.
Read More
UnitedHealth: The More It Drops, The More I'll Buy
Published: August 04, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated's Q2 earnings and margins disappointed due to rising medical cost trends, but core profitability remains solid. A management shakeup, including a new CEO and CFO, aims to restore confidence and address cost pressures through fresh leadership. Guidance for FY 2025 implies solid profitability in the core business, despite threats from higher medical costs.
Read More
UnitedHealth: Why This Giant's Pain Might Pay Off
Published: August 04, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth reported Q2-FY25 revenue of $111.6 billion, up 12.9% YoY, driven by UnitedHealthcare and Optum divisions. A $6.5 billion medical cost overrun led to a sharp rise in MCR to 89.4% and cut FY25 EPS outlook. Medicare Advantage enrollment grew by 650,000 members, offsetting pressure from competitor exits and pricing missteps in high-cost PPO plans.
Read More
Options Corner: UNH Steep Decline
Published: August 01, 2025 by: Schwab Network
Sentiment: Negative
UnitedHealth (UNH) shares have plummeted to the downside in a strong downtrend thus far in 2025. Tom White looks at the healthcare company and discusses its weight on the Dow Jones Industrial Avg.
Read More
UnitedHealth: The Disappointment Continues
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Negative
UnitedHealth Group Incorporated faces ongoing structural headwinds, poor execution, and a dramatic EPS reset, making a quick recovery highly unlikely. Management's guidance lacks confidence, with 2025 adjusted EPS slashed to $16, down substantially from its original outlook. While management has postured for further improvements through 2027, investors aren't buying into UNH's optimism yet.
Read More
Dow Jones: Microsoft Tops $4T Market Cap, But UnitedHealth Drop Pressures Index
Published: July 31, 2025 by: FXEmpire
Sentiment: Neutral
Dow slips as UnitedHealth weighs, while Microsoft hits $4T value and fuels Nasdaq gains. Traders eye Apple and Amazon earnings later today.
Read More
UnitedHealth Q2: Seeing More Clarity Could Be Positive For The Stock
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Neutral
UNH's Q2 FY2025 results significantly missed EPS expectations due to higher medical costs, and its updated FY2025 guidance came in largely below consensus. Higher MA cost trends continue to pressure margins in 2H 2025, and management now expects 2026 costs to rise further after miscalculation. Adjusted EPS is expected to decline 66% YoY in 2H FY2025, with FY2025 guidance at least $16 per share, implying a 42% YoY drop.
Read More
UnitedHealth: The Bottom Might Be In (Technical Analysis)
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Despite rising medical costs and margin pressures, UnitedHealth Group Incorporated remains solidly profitable, with strong sales growth and a robust net earnings base. UNH stock is now technically oversold, trading at just 12x 2026 estimated profits and offering a 3.3% dividend yield, making it attractive for value investors. A recovery is possible if UnitedHealth Group controls its medical care ratio and meets profit guidance, with even slight improvements likely to shift sentiment positively.
Read More
Trade Tracker: Steve Weiss sells UnitedHealth and buys more FTAI Aviation
Published: July 30, 2025 by: CNBC Television
Sentiment: Neutral
Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC's “Halftime Report” to detail his latest portfolio moves.
Read More
Here's the best time to buy UnitedHealth (UNH) stock, according to AI
Published: July 30, 2025 by: Finbold
Sentiment: Neutral
UnitedHealth's (NYSE: UNH) turbulent run in 2025 is escalating after the firm reported disappointing Q2 earnings results, but an AI platform has identified strategic entry points for long-term investors.
Read More
UnitedHealth Faces Long Road to Recovery
Published: July 30, 2025 by: WSJ
Sentiment: Negative
Returning CEO Stephen Hemsley is lowering expectations, but perhaps not enough.
Read More
UnitedHealth: Why This Healthcare Giant May Keep Sinking For The Rest Of The Year
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Negative
My bearish thesis on UnitedHealth Group Incorporated is playing out, with margins and earnings deteriorating as expected after Q2 FY25 results. The onus is on management to prove this is the bottom. Management's disappointing FY25 revenue guidance adds to challenges, making a turnaround story unlikely in the near term. Valuations may appear reasonable and even low depending on how you look at it, but I believe eroding earnings fundamentals make this a "no-go" for buys.
Read More
UnitedHealth Stock Is A Strong Buy Amid Unfavorable Medical Trends (Upgrade)
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Positive
Despite a double earnings miss, I am upgrading UnitedHealth Group Incorporated stock to Strong Buy due to its long-term growth potential and resilient fundamentals. UNH's current valuation prices in excessive pessimism; I believe earnings will recover as premium repricing and cost controls take effect. Management's transparency, share repurchases, and a growing dividend support my conviction in UNH's ability to outperform the S&P 500 over time.
Read More
UnitedHealth Group Incorporated (UNH) Q2 2025 Earnings Call Transcript
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated (NYSE:UNH ) Q2 2025 Earnings Conference Call July 29, 2025 8:45 AM ET Company Participants Bobby Hunter - CEO of Government Programs & Head of Medicare Insurance - Corporate Participant Daniel J. Schumacher - President Daniel Roger Kueter - Chief Executive Officer of UnitedHealthcare Employer & Individual - Corporate Participant Dhivya Suryadevara - Chief Executive Officer of Optum Financial Services - Corporate Participant Krista Nelson - Chief Executive Officer of UnitedHealthcare Community & State - Corporate Participant Timothy John Noel - Chief Executive Officer of UnitedHealthcare Business John F.
Read More
'Halftime' Committee Stocks on the Move: UnitedHealth, Merck, Royal Caribbean and Spotify
Published: July 29, 2025 by: CNBC Television
Sentiment: Negative
The Investment Committee debate some of their stocks on the move lower.
Read More
UnitedHealth Q2 Earnings Review: Still On The Canvas, While America Watches On
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Negative
UnitedHealth Group Incorporated's Q2 results show revenue growth but sharply lower earnings, with margins under pressure from higher medical costs and Medicare Advantage miscalculations. Management reinstated 2025 guidance but cut EPS forecasts in half, warning that recovery will be slow and margins will remain compressed for several years. Both UnitedHealthcare and Optum face significant headwinds, including regulatory risk, rising costs, and underperformance in value-based care and PBM businesses.
Read More
UnitedHealth: Buy This Generational Wealth Compounder While It's On Sale
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth's stock decline is overdone; DOJ investigation risk is likely manageable, with historical precedent suggesting a fine and agreement as the worst-case outcome. Medicaid margin pressures are temporary, with pricing power expected to return in 2026, restoring profitability for UnitedHealth and peers. Insider buying and a strong management track record reinforce my conviction in UnitedHealth's long-term compounding potential and resilience.
Read More
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH misses Q2 earnings estimates as surging medical costs slash EPS 40%, despite revenue growth and Optum Rx strength.
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000